Marta Dratwa

653 total citations
19 papers, 449 citations indexed

About

Marta Dratwa is a scholar working on Physiology, Oncology and Immunology. According to data from OpenAlex, Marta Dratwa has authored 19 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Marta Dratwa's work include Telomeres, Telomerase, and Senescence (7 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Research and Treatments (3 papers). Marta Dratwa is often cited by papers focused on Telomeres, Telomerase, and Senescence (7 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Research and Treatments (3 papers). Marta Dratwa collaborates with scholars based in Poland, Belgium and Israel. Marta Dratwa's co-authors include Katarzyna Bogunia‐Kubik, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, Grzegorz Mazur, Rafał Poręba, Anna Wojakowska, Helena Martynowicz, Mieszko Więckiewicz and Dariusz P. Danel and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Marta Dratwa

19 papers receiving 446 citations

Peers

Marta Dratwa

PHYSI

CMT

ONCOL

HEMAT

Hitoshi Take Japan

Omotayo Arowojolu United States

Madhu P. Menon United States

Celeste Decker United States

Marilyn C. Towns United States

Yuta Kojima Japan

Lucila Sackmann‐Sala United States

Byeong Jin Ye South Korea

Mohsen Esmaeili Iran

Hitoshi Take Japan

Marta Dratwa

38 ×0.2

PHYSI

147 ×0.9

24 ×0.3

CMT

40 ×0.7

ONCOL

21 ×0.3

HEMAT

Citations per year, relative to Marta Dratwa Marta Dratwa (= 1×) peers Hitoshi Take

Countries citing papers authored by Marta Dratwa

Since Specialization

Citations

This map shows the geographic impact of Marta Dratwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Dratwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Dratwa more than expected).

Fields of papers citing papers by Marta Dratwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Dratwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Dratwa. The network helps show where Marta Dratwa may publish in the future.

Co-authorship network of co-authors of Marta Dratwa

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Dratwa. A scholar is included among the top collaborators of Marta Dratwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Dratwa. Marta Dratwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dratwa, Marta, Anna Czyż, Maria Bieniaszewska, et al.. (2024). MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT. Archivum Immunologiae et Therapiae Experimentalis. 72(1). 2 indexed citations

Dratwa, Marta, et al.. (2023). Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma. Scientific Reports. 13(1). 15792–15792. 4 indexed citations

Dratwa, Marta, et al.. (2023). Pro- and anti-inflammatory cytokines and growth factors in patients undergoing in vitro fertilization procedure treated with prednisone. Frontiers in Immunology. 14. 1250488–1250488. 6 indexed citations

Wicherska‐Pawłowska, Katarzyna, Katarzyna Bogunia‐Kubik, Piotr Łacina, et al.. (2022). Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia. International Journal of Molecular Sciences. 23(17). 9593–9593. 3 indexed citations

Poręba, Rafał, Paweł Gać, Katarzyna Bogunia‐Kubik, et al.. (2022). Genetic Variants of the TERT Gene and Telomere Length in Obstructive Sleep Apnea. Biomedicines. 10(11). 2755–2755. 3 indexed citations

Dratwa, Marta, Barbara Wysoczańska, Joanna Wietrzyk, et al.. (2022). Relationship between Telomere Length, TERT Genetic Variability and TERT, TP53, SP1, MYC Gene Co-Expression in the Clinicopathological Profile of Breast Cancer. International Journal of Molecular Sciences. 23(9). 5164–5164. 12 indexed citations

Więckiewicz, Mieszko, Rafał Poręba, Paweł Gać, et al.. (2022). Assessment of Telomerase Reverse Transcriptase Single Nucleotide Polymorphism in Sleep Bruxism. Journal of Clinical Medicine. 11(3). 525–525. 9 indexed citations

Dratwa, Marta, Barbara Wysoczańska, Aleksandra Butrym, et al.. (2021). TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia. Scientific Reports. 11(1). 23301–23301. 10 indexed citations

Rybka, Justyna, Katarzyna Bogunia‐Kubik, Elżbieta Kalicińska, et al.. (2021). Analysis of Polymorphism in the Genes TLR3, TLR4 and TLR9 in Patients with Acute Myeloid Leukemia. Blood. 138(Supplement 1). 4470–4470. 2 indexed citations

10.

Dratwa, Marta, et al.. (2020). Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro. Experimental Cell Research. 396(1). 112298–112298. 11 indexed citations

11.

Dratwa, Marta, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, & Katarzyna Bogunia‐Kubik. (2020). TERT—Regulation and Roles in Cancer Formation. Frontiers in Immunology. 11. 589929–589929. 200 indexed citations

12.

Więckiewicz, Mieszko, Katarzyna Bogunia‐Kubik, Grzegorz Mazur, et al.. (2020). Genetic basis of sleep bruxism and sleep apnea—response to a medical puzzle. Scientific Reports. 10(1). 7497–7497. 82 indexed citations

13.

Iwaszko, Milena, Jerzy Świerkot, Marta Dratwa, et al.. (2020). Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis. The Pharmacogenomics Journal. 20(6). 760–769. 14 indexed citations

14.

Świerkot, Jerzy, Marta Dratwa, Milena Iwaszko, et al.. (2020). Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment. Archivum Immunologiae et Therapiae Experimentalis. 68(4). 24–24. 11 indexed citations

15.

Łacina, Piotr, et al.. (2020). Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma. Molecular Carcinogenesis. 60(2). 106–112. 7 indexed citations

16.

Wysoczańska, Barbara, Marta Dratwa, Katarzyna Gębura, et al.. (2019). <p>Variability within the human <em>TERT</em> gene, telomere length and predisposition to chronic lymphocytic leukemia</p>. OncoTargets and Therapy. Volume 12. 4309–4320. 15 indexed citations

17.

Dratwa, Marta, Jerzy Świerkot, Lucyna Korman, et al.. (2018). Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA. 92(S2). 38–41. 13 indexed citations

18.

Corazza, Francis, et al.. (2011). Renal biopsy findings in Belgium: a retrospective single center analysis.. PubMed. 66(2). 104–9. 18 indexed citations

19.

Verbeelen, D., Axel Bossuyt, Johan Smitz, et al.. (1989). Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.. PubMed. 31(1). 6–11. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact